» Articles » PMID: 21208161

The Contribution of Mannose Binding Lectin to Reperfusion Injury After Ischemic Stroke

Overview
Date 2011 Jan 7
PMID 21208161
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

After complement system (CS) activation, the sequential production of complement products increases cell injury and death through opsonophagocytosis, cytolysis, adaptive, and inflammatory cell responses. These responses potentiate cerebral ischemia-reperfusion (IR) injury after ischemic stroke and reperfusion. Activation of the CS via mannose binding lectin (MBL)-initiated lectin pathway is known to increase tissue damage in response to IR in muscle, myocardium and intestine tissue. In contrast, the contribution of this pathway to cerebral IR injury, a neutrophil-mediated event, is less clear. Therefore, we investigated the potential protective role of MBL deficiency in neutrophil-mediated cerebral injury after IR. Using an intraluminal filament method, neutrophil activation and cerebral injury were compared between MBL-deficient and wild type C57Bl/6 mice subjected to 60 minutes of MCA ischemia and reperfusion. Systemic neutrophil activation was not decreased in MBL-deficient animals after IR. In MBL-deficient animals, cerebral injury was significantly decreased only in the striatum (p < 0.05). Despite MBL deficiency, C3 depositions were evident in the injured hemisphere during reperfusion. These results indicate that while MBL deficiency results in a modest protection of a sub-cortical brain region during IR, redundant complement pathway activation may overwhelm further beneficial effects of MBL deficiency during reperfusion.

Citing Articles

PACAP glycosides promote cell outgrowth in vitro and reduce infarct size after stroke in a preclinical model.

Bernard K, Dickson D, Anglin B, Heien M, Polt R, Morrison H Neurosci Lett. 2024; 836:137883.

PMID: 38914278 PMC: 11384287. DOI: 10.1016/j.neulet.2024.137883.


Insight into the Neuroprotective Effect of Genistein-3'-Sodium Sulfonate Against Neonatal Hypoxic-Ischaemic Brain Injury in Rats by Bioinformatics.

Xie T, Shuang L, Liu G, Zhao S, Yuan Z, Cai H Mol Neurobiol. 2022; 60(2):807-819.

PMID: 36370154 PMC: 9849302. DOI: 10.1007/s12035-022-03123-8.


Aberrant Complement System Activation in Neurological Disorders.

Ziabska K, Ziemka-Nalecz M, Pawelec P, Sypecka J, Zalewska T Int J Mol Sci. 2021; 22(9).

PMID: 33925147 PMC: 8125564. DOI: 10.3390/ijms22094675.


Complement Initiation Varies by Sex in Intestinal Ischemia Reperfusion Injury.

Wu M, Rowe J, Fleming S Front Immunol. 2021; 12:649882.

PMID: 33868287 PMC: 8047102. DOI: 10.3389/fimmu.2021.649882.


Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury.

Yin P, Wei Y, Wang X, Zhu M, Feng J Front Neurol. 2018; 9:617.

PMID: 30131754 PMC: 6090140. DOI: 10.3389/fneur.2018.00617.


References
1.
Thomas A, Gasque P, Vaudry D, Gonzalez B, Fontaine M . Expression of a complete and functional complement system by human neuronal cells in vitro. Int Immunol. 2000; 12(7):1015-23. DOI: 10.1093/intimm/12.7.1015. View

2.
Costa C, Zhao L, Shen Y, Su X, Hao L, Colgan S . Role of complement component C5 in cerebral ischemia/reperfusion injury. Brain Res. 2006; 1100(1):142-51. DOI: 10.1016/j.brainres.2006.05.029. View

3.
De Simoni M, Rossi E, Storini C, Pizzimenti S, Echart C, Bergamaschini L . The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q. Am J Pathol. 2004; 164(5):1857-63. PMC: 1615651. DOI: 10.1016/S0002-9440(10)63744-3. View

4.
Spiegelman B, Frank M, Green H . Molecular cloning of mRNA from 3T3 adipocytes. Regulation of mRNA content for glycerophosphate dehydrogenase and other differentiation-dependent proteins during adipocyte development. J Biol Chem. 1983; 258(16):10083-9. View

5.
Storini C, Rossi E, Marrella V, Distaso M, Veerhuis R, Vergani C . C1-inhibitor protects against brain ischemia-reperfusion injury via inhibition of cell recruitment and inflammation. Neurobiol Dis. 2005; 19(1-2):10-7. DOI: 10.1016/j.nbd.2004.11.001. View